Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism

Clinical and Applied Thrombosis/Hemostasis- United States

doi 10.1177/1076029618758955

Full Text

Abstract

Available in

Categories

Date

March 8, 2018

Authors

Craig I. Coleman

Jan Beyer-Westendorf

Charles E. Mahan

Alex C. Spyropoulos

Publisher

SAGE Publications

Related search

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Journal of Vascular Surgery: Venous and Lymphatic Disorders

Cardiovascular Medicine

English

Rivaroxaban Versus Warfarin Treatment Among Morbidly Obese Patients With Venous Thromboembolism: Comparative Effectiveness, Safety, and Costs

Thrombosis Research

English

Venous Thromboembolism Prophylaxis After TKA: Aspirin, Warfarin, Enoxaparin, or Factor Xa Inhibitors?

Clinical Orthopaedics and Related Research

Sports Medicine

English

Long-Term Rivaroxaban for the Treatment of Acute Venous Thromboembolism in Patients With Active Cancer in a Prospective Multicenter Trial

Korean Journal of Internal Medicine

Internal Medicine

English

Pcv138 - Treatment Patterns of Patients With Venous Thromboembolism Treated With Oral Anticoagulants in England

Value in Health

Occupational Health

English

Treating Venous Thromboembolism in Patients With Cancer

Expert Review of Hematology

English

Ethnicity of Patients With Venous Thromboembolism

Circulation Journal

Cardiovascular Medicine

English

Symptomatic Venous Thromboembolism After Non-Operatively Treated Foot or Ankle Injury

Journal of Orthopaedic Research

Sports Medicine

English

Primary Prophylaxis for Venous Thromboembolism in Patients Undergoing Cardiac or Thoracic Surgery

Cochrane Database of Systematic Reviews

English